share_log

Maxim Group Initiates Coverage On Virios Therapeutics With Buy Rating, Announces Price Target of $1

Maxim Group Initiates Coverage On Virios Therapeutics With Buy Rating, Announces Price Target of $1

Maxim Group發起對Virios Therapeutics的買入評級,宣佈目標價格爲1美元。
Benzinga ·  06/20 07:47

Maxim Group analyst Jason McCarthy initiates coverage on Virios Therapeutics (NASDAQ:VIRI) with a Buy rating and announces Price Target of $1.

Maxim集團分析師傑森·麥卡錫以買入評級啓動了對Virios Therapeutics(納斯達克股票代碼:VIRI)的報道,並宣佈目標股價爲1美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論